4.2 Article

Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2-6

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Validation of the FENCE Risk Groups for Prediction of Febrile Neutropenia With First-Cycle Chemotherapy

Razan Zatarah et al.

Summary: This study validated the FENCE score in predicting the risk of febrile neutropenia in the first cycle of chemotherapy, showing moderate discriminatory ability in classifying patients into risk groups.

JNCI CANCER SPECTRUM (2022)

Article Oncology

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

J. Klastersky et al.

ANNALS OF ONCOLOGY (2016)

Review Oncology

Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review

Gary H. Lyman et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)